Good news! Healthier with AI! AI chatbots are personalizable, available at any time without appointment etc.
Note that this Therabot is still fairly primitive. It is only a text-based chatbot.
"... People in the study also reported they could trust and communicate with the system, known as Therabot, to a degree that is comparable to working with a mental health professional.
The trial consisted of 106 people from across the United States diagnosed with major depressive disorder, generalized anxiety disorder, or an eating disorder. Participants interacted with Therabot through a smartphone app by typing out responses to prompts about how they were feeling or initiating conversations when they needed to talk.
People diagnosed with depression experienced a 51% average reduction in symptoms, leading to clinically significant improvements in mood and overall well-being, the researchers report.
Participants with generalized anxiety reported an average reduction in symptoms of 31%, with many shifting from moderate to mild anxiety, or from mild anxiety to below the clinical threshold for diagnosis.
Among those at risk for eating disorders—who are traditionally more challenging to treat—Therabot users showed a 19% average reduction in concerns about body image and weight, which significantly outpaced a control group that also was part of the trial. ..."
"Researchers ... recently published the results of the first-ever clinical trial of AI therapy.
The trial involved 210 participants who were randomly assigned to a 4-week program with Therabot, a generative AI chatbot trained on a curated dataset of therapeutic conversations. ...
patients with depression, anxiety, or an eating disorder reported an average symptom reduction of 51 percent, 31 percent, and 19 percent, respectively."
"... The AI chatbot Therabot is a text-based multi-thread app that is compatible with both iOS and Android smartphones. Therabot was fine-tuned on mental health conversations created by mental health experts, including a clinical psychologist and board-certified psychiatrist, who were on the research team. Moreover, the conversations were also peer-reviewed with evidence-based modalities, which consisted mainly of cognitive behavior therapy (CBT), a structured form of talk therapy. ..."
From the abstract:
"Background
Generative artificial intelligence (Gen-AI) chatbots hold promise for building highly personalized, effective mental health treatments at scale, while also addressing user engagement and retention issues common among digital therapeutics. We present a randomized controlled trial (RCT) testing an expert–fine-tuned Gen-AI–powered chatbot, Therabot, for mental health treatment.
Methods
We conducted a national, randomized controlled trial of adults (N=210) with clinically significant symptoms of major depressive disorder (MDD), generalized anxiety disorder (GAD), or at clinically high risk for feeding and eating disorders (CHR-FED). Participants were randomly assigned to a 4-week Therabot intervention (N=106) or waitlist control (WLC; N=104).
WLC participants received no app access during the study period but gained access after its conclusion (8 weeks).
Participants were stratified into one of three groups based on mental health screening results: those with clinically significant symptoms of MDD, GAD, or CHR-FED.
Primary outcomes were symptom changes from baseline to postintervention (4 weeks) and to follow-up (8 weeks).
Secondary outcomes included user engagement, acceptability, and therapeutic alliance (i.e., the collaborative patient and therapist relationship).
Cumulative-link mixed models examined differential changes. Cohen’s d effect sizes were unbounded and calculated based on the log-odds ratio, representing differential change between groups.
Results
Therabot users showed significantly greater reductions in symptoms of
MDD (mean changes: −6.13 [standard deviation {SD}=6.12] vs. −2.63 [6.03] at 4 weeks; −7.93 [5.97] vs. −4.22 [5.94] at 8 weeks; d=0.845–0.903),
GAD (mean changes: −2.32 [3.55] vs. −0.13 [4.00] at 4 weeks; −3.18 [3.59] vs. −1.11 [4.00] at 8 weeks; d=0.794–0.840), and
CHR-FED (mean changes: −9.83 [14.37] vs. −1.66 [14.29] at 4 weeks; −10.23 [14.70] vs. −3.70 [14.65] at 8 weeks; d=0.627–0.819) relative to controls at postintervention and follow-up.
Therabot was well utilized (average use >6 hours), and participants rated the therapeutic alliance as comparable to that of human therapists.
Conclusions
This is the first RCT demonstrating the effectiveness of a fully Gen-AI therapy chatbot for treating clinical-level mental health symptoms.
The results were promising for MDD, GAD, and CHR-FED symptoms. Therabot was well utilized and received high user ratings.
Fine-tuned Gen-AI chatbots offer a feasible approach to delivering personalized mental health interventions at scale, although further research with larger clinical samples is needed to confirm their effectiveness and generalizability. ..."
Weekly Progress Roundup - by Malcolm Cochran - Doomslayer